Meeting
2019 ASCO Quality Care Symposium
Pathways impact on OCM drug cost.
Authors
Valerie Pracilio Csik
Sidney Kimmel Cancer Center, Philadelphia, PA
Valerie Pracilio Csik, Jared Minetola, Karen Walsh, Michael J. Ramirez, Mark Hurwitz
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cost, Value, and Policy; Health Equity and Disparities
Track
Cost, Value, and Policy,Health Care Access, Equity, and Disparities
Sub Track
Value/Cost of Care
Citation
J Clin Oncol 37, 2019 (suppl 27; abstr 109)
DOI
10.1200/JCO.2019.37.27_suppl.109
Abstract #
109
Poster Bd #
H8
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Quality Care Symposium
The Oncology Care Model and lung cancer: Retrospective review of claims and clinical data at a large academic medical center.
First Author: Chetan Vakkalagadda
Poster
2019 ASCO Quality Care Symposium
Can utilization of clinical pathways (CPs) effectively reduce drug spending (DS) within the Oncology Care Model (OCM)?
First Author: Andrew Allan Hertler
First Author: Valerie P Csik
Poster
2023 ASCO Quality Care Symposium
Trend in breakdown of total cost of care for medical oncology over time: Learnings from the Oncology Care Model and implications for future oncology value-based care.
First Author: Leah Owens